TY - JOUR
T1 - Biology of chronic lymphocytic leukemia
AU - Caligaris-Cappio, Federico
PY - 2000/3
Y1 - 2000/3
N2 - B-cell chronic lymphocytic leukemia (CLL) lies at the cross-roads of hematology, immunology and oncology for at least three major reasons: (a) it is the prototype of human malignancies that primarily involve defects in the induction of apoptosis; (b) CLL patients develop a severe immunodeficiency with progressive hypogammaglobulinemia; and (c) they have a high prevalence of autoimmune phenomena. Recent advances in the biology of the malignant cell in CLL lead to a scenario comprised of two basic elements: first, CLL cells are optimally organized to survive in their niches because their ability to undergo apoptosis is severely hampered; second, they have a microenvironment-dependence that promotes their extended survival, a situation that arises most probably through direct cell-to-cell contacts. In addition, CLL cells themselves are the major accessory cells in CLL, but are inefficient antigen-presenting cells. This latter defect may provide a clue to reinterpret the events of immunodeficiency and autoimmunity.
AB - B-cell chronic lymphocytic leukemia (CLL) lies at the cross-roads of hematology, immunology and oncology for at least three major reasons: (a) it is the prototype of human malignancies that primarily involve defects in the induction of apoptosis; (b) CLL patients develop a severe immunodeficiency with progressive hypogammaglobulinemia; and (c) they have a high prevalence of autoimmune phenomena. Recent advances in the biology of the malignant cell in CLL lead to a scenario comprised of two basic elements: first, CLL cells are optimally organized to survive in their niches because their ability to undergo apoptosis is severely hampered; second, they have a microenvironment-dependence that promotes their extended survival, a situation that arises most probably through direct cell-to-cell contacts. In addition, CLL cells themselves are the major accessory cells in CLL, but are inefficient antigen-presenting cells. This latter defect may provide a clue to reinterpret the events of immunodeficiency and autoimmunity.
UR - http://www.scopus.com/inward/record.url?scp=0034160333&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034160333&partnerID=8YFLogxK
U2 - 10.1046/j.1468-0734.2000.00001.x
DO - 10.1046/j.1468-0734.2000.00001.x
M3 - Article
C2 - 11491097
AN - SCOPUS:0034160333
VL - 4
SP - 5
EP - 21
JO - Reviews in Clinical and Experimental Hematology
JF - Reviews in Clinical and Experimental Hematology
SN - 1127-0020
IS - 1
ER -